Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: J Int Assoc Provid AIDS Care. 2015 Oct 30;15(5):400–405. doi: 10.1177/2325957415614650

Table 1.

Demographic and Clinical Characteristics by HIV and Hepatitis C (HCV) status

HIV
Negative
HIV
Positive
Overall
ANOVA

p-value
(Mean ± SD or n (%)) HCV
Negative
(n=120)
HCV

Positive

(n=15)
P-
Value
HCV
Negative
(n=21)
HCV
Positive
(n=46)
P-
Value
Sociodemographic
  Age (in years) 28.4 ± 6.5 34.6 ± 8.6 0.001 31.0 ± 5.4 36.1 ± 5.2 0.0004 <0.001
  Female 16 (13%) 2 (13%) 0.99* 5 (24%) 2 (4%) 0.03* 0.11*
  Amerindios
  White (1)
22 (18%)
198 (82%)
5 (33%)
10 (67%)
0.18* 9 (43%)
12 (57%)
14 (30%)
32 (70%)
0.41 0.06
  Recruitment Site:
    Cenareso
    Fundai

105 (88%)

15 (13%)

10 (67%)

5 (33%)
0.05*
7 (33%)

14 (67%)

17 (37%)

29 (63%)
0.77 <0.001
Drug, Smoking, Alcohol
  Cigarette smoker (1) 109 (91%) 11 (73%) 0.06* 15 (71%) 38 (84%) 0.32* 0.03*
Hazardous alcohol consumption (1,2) 59 (50%) 9 (60%) 0.45 14 (67%) 28 (61%) 0.65 0.34
  In the past 6 months: (1)
    Injection Drug User
    Non-Injection Drug User
    Clean

7 (6%)

104 (87%)

9 (8%)

2 (13%)

13 (87%)

0 (0%)
0.30*
1 (5%)

18 (86%)

2 (10%)

11 (24%)

28 (62%)

6 (13%)
0.14* 0.01*
  Coca Paste user in past 6 mo 87 (73%) 11 (73%) 0.99 16 (76%) 29 (63%) 0.29 0.60
Dietary Intake (24 Hour Recall)
  Total Caloric intake (kcal) 2829.1 ± 1120.5 3257.2 ± 1238.2 0.17 2597.0 ± 927.6 2817.0 ± 929.6 0.37 0.34
  Fat intake (% of total kcal) 31.7 ± 8.3 27.8 ± 5.4 0.07 29.5 ± 10.7 29.3 ± 9.7 0.94 0.17
  Total fat (g) 100 ± 51 105 ± 57 0.75 91 ± 45 95 ± 46 0.77 0.77
  Mono-unsaturated fat (g) 32.0 ± 17.5 34.5 ± 18.7 0.61 29.0 ± 15.9 29.7 ± 17.7 0.89 0.69
  Poly-unsaturated fat (g) 18.8 ± 12.6 20.9 ± 17.5 0.57 15.2 ± 104 15.4 ± 8.4 0.93 0.20
  Saturated fat (g) 36.1 ± 20.7 34.8 ± 15.6 0.82 34.1 ± 21.2 32.6 ± 20.1 0.78 0.79
  Cholesterol intake (mg)* 428 ± 241 376 ± 209 0.42 291 ± 158 337 ± 233 0.41 0.02
Clinical Measures
  BMI (kg/m2) 24.8 ± 4.2 23.7 ± 3.8 0.36 22.2 ± 2.4 23.1 ± 3.0 0.23 0.008
  Systolic blood pressure (mmHg) 115 ± 9 115 ± 12 0.77 108 ± 12 112 ± 17 0.34 0.03
  Diastolic blood pressure(mmHg) 71 ± 7 72 ± 9 0.71 69 ± 9 71 ± 11 0.56 0.80
Laboratory
  Total Cholesterol (mg/dL) 176 ± 40 149 ± 30 0.01 155 ± 24 144 ± 31 0.16 <0.001
  HDL Cholesterol (mg/dL) 46 ± 12 47 ± 18 0.81 39 ± 14 39 ± 13 0.86 0.005
  LDL Cholesterol (mg/dL) 102 ± 34 77 ± 25 0.007 89 ± 21 78 ± 24 0.09 <0.001
  TC:HDL ratio 4.1 ± 1.5 3.5 ± 1.1 0.12 4.6 ± 2.0 4.1 ± 1.7 0.29 0.19
  Triglycerides (mg/dL) 142 ± 75 125 ± 68 0.40 140 ± 57 135 ± 61 0.72 0.79
C-Reactive Protein – Reactive (3) 24 (20%) 3 (20%) 0.99* 9 (43%) 18 (39%) 0.77 0.02
*

Fisher’s Exact test used because 25% or more of cells had expected counts less than 5.0

(1)

Race, Alcohol, cigarette smoking, and drug use missing data for one participant.

(2)

Hazardous drinker as defined by The National Institute on Alcohol Abuse and Alcoholism. (Hazardous alcohol use definition: 7 drinks per week or 3 drinks per occasion for women and 14 drinks per week or 4 drinks per occasion in men.)

(3)

C-reactive protein was quantified by PCR-latex (Wiener Laboratory, Rosario, Argentina) which detects levels above 6 mg/l as positive.